Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HSD17B2 |
| Upstream (Parents) |
|---|
| (<<) BDH1 → HSD17B2 |
| (<<) HSD11B1 → HSD17B2 |
| (<<) MT1F → HSD17B2 |
| (<<) MT1G → HSD17B2 |
| (<<) ORM1 → HSD17B2 |
| (<<) RDH16 → HSD17B2 |
| (<<) SAA4 → HSD17B2 |
| (<<) SOD1 → HSD17B2 |
| Downstream (Children) |
|---|
| HSD17B2 → AQP3 (>>) |
| HSD17B2 → ARSA (>>) |
| HSD17B2 → CALB1 (>>) |
| HSD17B2 → CASP7 (>>) |
| HSD17B2 → CAT (>>) |
| HSD17B2 → CBS (>>) |
| HSD17B2 → CEBPD (>>) |
| HSD17B2 → CSTB (>>) |
| HSD17B2 → CXCL2 (>>) |
| HSD17B2 → CYP1A2 (>>) |
| HSD17B2 → CYP4F2 (>>) |
| HSD17B2 → DUSP10 (>>) |
| HSD17B2 → DVL3 (>>) |
| HSD17B2 → ELF4 (>>) |
| HSD17B2 → ENC1 (>>) |
| HSD17B2 → FGFR2 (>>) |
| HSD17B2 → FNDC4 (>>) |
| HSD17B2 → GAD1 (>>) |
| HSD17B2 → GOT1 (>>) |
| HSD17B2 → GRN (>>) |
| HSD17B2 → HS3ST2 (>>) |
| HSD17B2 → HYAL1 (>>) |
| HSD17B2 → LIPG (>>) |
| HSD17B2 → MAT2A (>>) |
| HSD17B2 → MMP9 (>>) |
| HSD17B2 → MT1P2 (>>) |
| HSD17B2 → NNMT (>>) |
| HSD17B2 → NRG1 (>>) |
| HSD17B2 → PLCG2 (>>) |
| HSD17B2 → PNPLA3 (>>) |
| HSD17B2 → RBKS (>>) |
| HSD17B2 → RHBDL1 (>>) |
| HSD17B2 → RHOD (>>) |
| HSD17B2 → RNASE4 (>>) |
| HSD17B2 → SET (>>) |
| HSD17B2 → SLC16A6 (>>) |
| HSD17B2 → TCF7L1 (>>) |
| HSD17B2 → VTCN1 (>>) |
